Senti Biosciences (SNTI) Return on Capital Employed (2021 - 2025)
Senti Biosciences has reported Return on Capital Employed over the past 5 years, most recently at 181.09% for Q4 2025.
- For Q4 2025, Return on Capital Employed fell 8666.0% year-over-year to 181.09%; the TTM value through Dec 2025 reached 181.09%, down 8666.0%, while the annual FY2025 figure was 113.58%, 4967.0% down from the prior year.
- Return on Capital Employed for Q4 2025 was 181.09% at Senti Biosciences, down from 136.48% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 16.23% in Q4 2021 and troughed at 181.09% in Q4 2025.
- A 5-year average of 74.09% and a median of 76.82% in 2025 define the central range for Return on Capital Employed.
- On a YoY basis, Return on Capital Employed climbed as much as 1611bps in 2025 and fell as far as -8666bps in 2025.
- Year by year, Return on Capital Employed stood at 16.23% in 2021, then plummeted by -140bps to 38.95% in 2022, then tumbled by -111bps to 82.09% in 2023, then fell by -15bps to 94.44% in 2024, then crashed by -92bps to 181.09% in 2025.
- Business Quant data shows Return on Capital Employed for SNTI at 181.09% in Q4 2025, 136.48% in Q3 2025, and 98.33% in Q2 2025.